• FDA First Half Recap: Dermatology in 2024

  • Jul 3 2024
  • Duración: 40 m
  • Podcast

FDA First Half Recap: Dermatology in 2024

  • Resumen

  • Led by a flood of biologic therapies becoming available and progressing within the therapeutic pipeline, the field of dermatology finds itself in the midst of a watershed moment for many dermatologic conditions. To celebrate and recap the advancements occurring in the first half of 2024, the editorial team of HCPLive Dermatology sat down with James Del Rosso, DO, research director of JDR Dermatology Research and president of the American Acne and Rosacea Society, for more perspective on pipeline movement.

    Del Rosso, who also serves as an adjunct clinical professor of Dermatology at Touro University, takes a deep dive into several different disease states in dermatology and highlights how the news to emerge in the last 6 months, as well as prior to the close of 2023, has influenced real-world management.

    Más Menos
activate_WEBCRO358_DT_T2

Lo que los oyentes dicen sobre FDA First Half Recap: Dermatology in 2024

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.